Published 2025-02-01
“…Keerthy Sunder,1– 3,* Milan T Makale,4,* Miles Makale,5,* Jothsna Bodhanapati,2,* Kevin T Murphy,6,* Catherine A Dennen,7,* David Baron,8,* Panayotis K Thanos,9,10,* Colin Hanna,9,* John Wesson Ashford Jnr,11,* Kai-Uwe Lewandrowski,12,* Kenneth Blum3,8,10,* 1Department of Psychiatry, University California, UC Riverside School of Medicine, Riverside, CA, USA; 2Division of Neuromodulation Research, Karma Doctors & Karma TMS, Palm Springs, CA, USA; 3Sunder Foundation, Palm Springs, CA, USA; 4Department of Radiation Medicine and Applied
Sciences, University of California San Diego, La Jolla, CA, USA; 5Department of Psychology, University of California San Diego, San Diego, CA, USA; 6PeakLogic Inc., Del
Mar, CA, USA; 7Department of Family Medicine, Jefferson Health Northeast, Philadelphia, PA, USA; 8Division of Addiction Research & Education, Center for Sports, Exercise and Mental Health, Western University Health
Sciences, Pomona, CA, USA; 9Behavioral Neuropharmacology and Neuroimaging
Laboratory On Addictions (BNNLA), Research Institute On Addictions, Department of Pharmacology and Toxicology, Jacobs School of Medicine and Biomedical
Sciences, University at Buffalo, Buffalo, NY, USA; 10Department of Molecular Biology, Adelson School of Medicine, Ariel University, Ariel, Israel; 11Stanford University, Psychiatric /Public Mental Health & Population
Sciences Palo Alto, Stanford, CA, USA; 12Department of Orthopaedics, Fundación Universitaria Sanitas, Bogotá D.C., Colombia*These authors contributed equally to this workCorrespondence: Kenneth Blum, Email drd2gene@gmail.comAbstract: Major Depressive Disorder (MDD) and Generalized Anxiety Disorder (GAD) are prevalent comorbidities related to a greater likelihood of poor treatment outcomes and prolonged treatment for Reward Deficiency Syndrome (RDS) behaviors. …”
Get full text
Article
